GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
| Revenue (Most Recent Fiscal Year) | $43.07B |
| Net Income (Most Recent Fiscal Year) | $7.54B |
| PE Ratio (Current Year Earnings Estimate) | 12.60 |
| PE Ratio (Trailing 12 Months) | 13.46 |
| PEG Ratio (Long Term Growth Estimate) | 3.69 |
| Price to Sales Ratio (Trailing 12 Months) | 2.88 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 5.89 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.75 |
| Pre-Tax Margin (Trailing 12 Months) | 22.66% |
| Net Margin (Trailing 12 Months) | 17.47% |
| Return on Equity (Trailing 12 Months) | 46.75% |
| Return on Assets (Trailing 12 Months) | 11.53% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.82 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.54 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.92 |
| Inventory Turnover (Trailing 12 Months) | 1.50 |
| Book Value per Share (Most Recent Fiscal Quarter) | $10.32 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.68 |
| Earnings per Share (Most Recent Fiscal Year) | $4.54 |
| Diluted Earnings per Share (Trailing 12 Months) | $3.70 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Common Shares Outstanding | 2.04B |
| Free Float | 1.83B |
| Market Capitalization | $124.04B |
| Average Volume (Last 20 Days) | 6.38M |
| Beta (Past 60 Months) | 0.46 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 10.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 15.74% |
| Annual Dividend (Based on Last Quarter) | $1.70 |
| Dividend Yield (Based on Last Quarter) | 2.80% |